KDM5B

protein-coding

lysine demethylase 5B, the group of AT-rich interaction domain containing|PHD finger proteins|Lysine demethylases

Gene summary

This gene encodes a lysine-specific histone demethylase that belongs to the jumonji/ARID domain-containing family of histone demethylases. The encoded protein is capable of demethylating tri-, di- and monomethylated lysine 4 of histone H3. This protein plays a role in the transcriptional repression or certain tumor suppressor genes and is upregulated in certain cancer cells. This protein may also play a role in genome stability and DNA repair. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]

Previous symbols:
  • JARID1B

MANE transcript

NM_006618.5

Inheritance

AR, AD, SD

ClinVar variants

P:123U:350B:78

Top phenotype

Intellectual developmental disorder, autosomal recessive 65

gnomAD constraint

pLI —, LoF o/e 0.44

Max pathogenic AF

—

Genomic locus

chr1:202,724,495-202,808,487

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~84.0 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

autosomal recessive non-syndromic intellectual disabilitySUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0019502

Submitter: Orphanet

neurodevelopmental disorderSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0700092

Submitter: G2P

intellectual developmental disorder, autosomal recessive 65LIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0020850

Submitter: Ambry Genetics

Tourette syndromeNO_KNOWN

Inheritance Pattern: Unknown

Disease ID:MONDO:0007661

Submitter: Labcorp Genetics (formerly Invitae)

intellectual developmental disorder, autosomal recessive 65STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0020850

Submitter: Labcorp Genetics (formerly Invitae)

intellectual disabilityMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0001071

Submitter: ClinGen

*KDM5B* was first reported in relation to autosomal recessive intellectual disability in 2018 (Faundes, et al., PMID: 29276005). At least 9 unique variants (e.g. missense, nonsense, frameshift, splice site, large deletion, etc.) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, and experimental evidence. Variants in this gene have been reported in at least 5 probands in 3 publications (PMIDs: 29276005, 34573379, 30409806). Nine variants (missense, nonsense, frameshift, splice site, large deletion) that have been reported in 5 probands in 3 publications (PMIDs: 29276005, 34573379, 30409806) are included in this curation. Please note that due to limitations of the scoring interface, a proband who was compound heterozygous for a splice variant and a large deletion was not able to be formally entered and scored at 2 points (PMID:30409806). This gene-disease association is also supported by animal models, in vitro functional assays, and biochemical function studies (PMIDs: 30409806, 22020125). Of note, this gene has also been implicated in autosomal dominant intellectual disability, autism, and development disorder. These will be assessed separately. Although this curation reached Definitive, the classification has been modified to Moderate due to the small number of probands reported in the literature. More evidence is needed to establish this relationship definitively. In summary, there is moderate evidence to support this gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on 3/1/2022 (SOP Version 8).

neurodevelopmental disorderSTRONG

Inheritance Pattern: SD

Disease ID:MONDO:0700092

Submitter: PanelApp Australia

intellectual developmental disorder, autosomal recessive 65STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0020850

Submitter: G2P

Clinical Genomic Database (CGD)

Intellectual developmental disorder, autosomal recessive 65AR

Manifestation: Craniofacial; Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision making, and avoidance of unnecessary testing

Comments: Heterozygous variants appear to be able to cause an incompletely penetrant phenotype

Refs: 29276005; 30409806Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to KDM5B variants in ClinVar

16 Conditions Cataloged
not providedTotal: 257
Inborn genetic diseasesTotal: 197
Intellectual disability, autosomal recessive 65Total: 95
KDM5B-related disorderTotal: 51
not specifiedTotal: 22
Neurodevelopmental disorderTotal: 10
Intellectual disabilityTotal: 3
See casesTotal: 3

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_006618.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
56
clinvar
5
clinvar
63
missense
1
clinvar
9
clinvar
311
clinvar
16
clinvar
1
clinvar
338
nonsense
13
clinvar
34
clinvar
9
clinvar
56
start loss
0
frameshift
19
clinvar
29
clinvar
13
clinvar
61
splice donor/acceptor (+/-2bp)
3
clinvar
15
clinvar
15
clinvar
33
Total3687350726551

Highest pathogenic variant AF is 0.00004275326

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 57 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_006618.5RefSeqNP_006609.327MANE Select
ENST00000367265.9EnsemblENSP00000356234.327MANE Select
NM_001314042.2RefSeqNP_001300971.128Standard
NM_001347591.2RefSeqNP_001334520.126Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Gene expression (Transcription)
  • Generic Transcription Pathway
  • HDMs demethylate histones
  • RNA Polymerase II Transcription
  • Chromatin modifying enzymes

Biological Process

  • negative regulation of transcription by RNA polymerase II
  • chromatin remodeling
  • regulation of transcription by RNA polymerase II
  • single fertilization
  • post-embryonic development

Molecular Function

  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • DNA binding
  • DNA-binding transcription factor activity
  • transcription corepressor activity
  • protein binding

Cellular Component

  • nucleus
  • nucleoplasm
  • cytosol
  • histone methyltransferase complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000367265
Coding exons
27
Length
82073
Individuals with no LoFs
125620
Homozygous LoFs
0
Heterozygous LoFs
128
Defined
125748
p
0.000509
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.787018470.8280.000045410098
Missense (PolyPhen)226331.320.682123976
Synonymous0.8222943120.9410.00001592954
Loss of Function4.964091.10.4390.00000581989

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000190.00018rare
Latino/Admixed American0.000350.00035rare
Ashkenazi Jewish0.000400.00040rare
East Asian0.00240.0024notable
Finnish0.000230.00023rare
European (Non-Finnish)0.000440.00043rare
South Asian0.000270.00026rare
Other0.000330.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Histone demethylase that demethylates 'Lys-4' of histone H3, thereby playing a central role in histone code (PubMed:24952722, PubMed:27214403, PubMed:28262558). Does not demethylate histone H3 'Lys-9' or H3 'Lys-27'. Demethylates trimethylated, dimethylated and monomethylated H3 'Lys-4'. Acts as a transcriptional corepressor for FOXG1B and PAX9. Favors the proliferation of breast cancer cells by repressing tumor suppressor genes such as BRCA1 and HOXA5 (PubMed:24952722). In contrast, may act as a tumor suppressor for melanoma. Represses the CLOCK-ARNTL/BMAL1 heterodimer-mediated transcriptional activation of the core clock component PER2 (By similarity). {ECO:0000250|UniProtKB:Q80Y84, ECO:0000269|PubMed:12657635, ECO:0000269|PubMed:16645588, ECO:0000269|PubMed:17320161, ECO:0000269|PubMed:17363312, ECO:0000269|PubMed:24952722, ECO:0000269|PubMed:26645689, ECO:0000269|PubMed:26741168, ECO:0000269|PubMed:27214403, ECO:0000269|PubMed:28262558}.;

Recessive Scores

pRec
0.128

Intolerance Scores

LoFtool
0.176
RVIS EVS
-1.72
RVIS percentile EVS
2.48

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.636

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.